David Ermert
Associate Professor (Docent) at Lund University | Greater Malmö Metropolitan Area, Sweden
David Ermert’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Associate Professor (Docent) at Lund University in September 2018 - Present
Principal Scientist at BioInvent International AB in April 2025 - Present
Senior Research Scientist at BioInvent International AB in April 2019 - March 2025
Research Scientist at BioInvent International AB in August 2018 - March 2019
Senior Researcher at Lund University in February 2014 - August 2018
Research Fellow at University of Massachusetts Medical School in January 2012 - March 2018
Researcher (Postdoktor) at Lund University in February 2011 - January 2014
Postdoktor with stipend at Umeå universitet in January 2010 - January 2011
Researcher PhD Student at Max Planck Institute for Infection Biology in May 2006 - January 2010
University of Tübingen, Master of Science - MS, July 2026
The University of Göttingen, Master of Science - MS, July 2026
Ludwig-Maximilians-Universität München, July 2026
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently five drug candidates in six ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors. The Company's validated, proprietary F.I.R.S.T™ technology platform identifies both targets and the antibodies that bind to them, generating many promising new immune-modulatory candidates to fuel the Company's own clinical development pipeline and providing licensing and partnering opportunities. The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com.
Discover more about Lund University
VP Intellectual Property at BioInvent International AB - European Patent Attorney, European Patent Litigator, Authorized Patent Attorney (Sweden)
VP Intellectual Property at BioInvent International AB
(September 2022 – Present)
Director Computational Biology at BioInvent International AB | Co-Founder at Queo Health
Co-Founder at Queo Health
(October 2022 – Present)
SVP Technical Operations at BioInvent International AB
SVP Technical Operations at BioInvent International AB
(January 2018 – Present)
Medical Director, APMMC | Tactical Biotech Advisor | Clinical Oncologist, Ph.D.
Medical Director at BioInvent International AB
(May 2024 – Present)
President and CEO at BioInvent International AB
UniTargetingResearch AS, a VC backed start up company in Bergen/Norway, has developed a unique technology for increasing protein production in mammalian cell systems for the GLP and GMP manufacturing process of recombinant proteins.
Chief Business Officer at BioInvent International AB
Octave Biotech Consulting assists biotech companies large and small with all their business development needs, including partnering strategies, due diligence, structuring and negotiating term sheets and legal agreements, financial modelling, non-dilutive financing for developm...
What is David Ermert email address?
Email David Ermert at [email protected] and [email protected]. This email is the most updated David Ermert's email found in 2026.
How to contact David Ermert?
To contact David Ermert send an email to [email protected] or [email protected]. (updated on November 30, 2025)
What company does David Ermert work for?
David Ermert works for Lund University.
What is David Ermert's role at Lund University?
David Ermert is Associate Professor (Docent)
What industry does David Ermert work in?
David Ermert works in the Research industry.
